CTKB – cytek biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Cytek Biosciences, Inc. (NASDAQ: CTKB) had its price target lowered by analysts at Piper Sandler from $10.00 to $8.50. They now have an "overweight" rating on the stock.
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
Cytek Biosciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Cytek Biosciences Reports First Quarter 2024 Financial Results
Form 4 Cytek Biosciences, Inc. For: May 13 Filed by: McCombe William D.
Form 10-Q Cytek Biosciences, Inc. For: Mar 31
Form 8-K Cytek Biosciences, Inc. For: May 08
Form ARS Cytek Biosciences, Inc. For: Dec 31
Form DEFA14A Cytek Biosciences, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.